Brexanolone: A New Hope? Updates on the Management of Postpartum Depression

<p>Mikaela M. Hofer, Pharm.D., (<a href='https://twitter.com/mikaelamhofer'>@mikaelamhofer</a>) identifies risk factors associated with postpartum depression, reviews current options for treatment and describes the potential place in therapy for brexanolone in treating postpartum depression.</p> <p>For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs <a href='https://twitter.com/MayoPharmRes'>@MayoPharmRes</a> or the host, Garrett E. Schramm, Pharm.D., <a href='https://twitter.com/garrett_schramm'>@garrett_schramm</a> on Twitter!</p> <p>You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>